FdaApplication
ANDA 202338
Identifiers
- fda_app_no: ANDA202338
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | ANDA |
| approval_date | 2013-06-28 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IMIPRAMINE PAMOATE | IMIPRAMINE PAMOATE | EQ 100MG HYDROCHLORIDE | CAPSULE;ORAL |
| IMIPRAMINE PAMOATE | IMIPRAMINE PAMOATE | EQ 150MG HYDROCHLORIDE | CAPSULE;ORAL |
| IMIPRAMINE PAMOATE | IMIPRAMINE PAMOATE | EQ 125MG HYDROCHLORIDE | CAPSULE;ORAL |
| IMIPRAMINE PAMOATE | IMIPRAMINE PAMOATE | EQ 75MG HYDROCHLORIDE | CAPSULE;ORAL |
4 products